Anti-CD19 chimeric antigen receptor T-cell therapy in B-cell lymphomas: current status and future directions
{{output}}
Aims: To review recent data and relevant of the role of anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for B-cell non-Hodgkin lymphoma (NHL). Methods: ... ...
